BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 12475787)

  • 1. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion.
    MacDonald PE; El-Kholy W; Riedel MJ; Salapatek AM; Light PE; Wheeler MB
    Diabetes; 2002 Dec; 51 Suppl 3():S434-42. PubMed ID: 12475787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility.
    Miki T; Minami K; Shinozaki H; Matsumura K; Saraya A; Ikeda H; Yamada Y; Holst JJ; Seino S
    Diabetes; 2005 Apr; 54(4):1056-63. PubMed ID: 15793244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA
    Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
    Scrocchi LA; Marshall BA; Cook SM; Brubaker PL; Drucker DJ
    Diabetes; 1998 Apr; 47(4):632-9. PubMed ID: 9568697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incretin notion and its relevance to diabetes.
    Habener JF
    Endocrinol Metab Clin North Am; 1993 Dec; 22(4):775-94. PubMed ID: 8125072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
    Holz GG
    Horm Metab Res; 2004; 36(11-12):787-94. PubMed ID: 15655710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
    Gromada J; Brock B; Schmitz O; Rorsman P
    Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):252-62. PubMed ID: 15569269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
    Gefel D; Barg Y; Zimlichman R
    Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
    Hansen L; Hartmann B; Mineo H; Holst JJ
    Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
    Ahrén B
    Bioessays; 1998 Aug; 20(8):642-51. PubMed ID: 9780839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-1 in NIDDM.
    Holst JJ
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S156-60. PubMed ID: 8894501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 and control of insulin secretion.
    Thorens B
    Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 is a physiological incretin in rat.
    Wang Z; Wang RM; Owji AA; Smith DM; Ghatei MA; Bloom SR
    J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
    Hui H; Yu R; Bousquet C; Perfetti R
    Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.
    Orskov C; Holst JJ; Nielsen OV
    Endocrinology; 1988 Oct; 123(4):2009-13. PubMed ID: 2901341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM.
    Thorens B; Waeber G
    Diabetes; 1993 Sep; 42(9):1219-25. PubMed ID: 8349031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1.
    Doyle ME; Egan JM
    Recent Prog Horm Res; 2001; 56():377-99. PubMed ID: 11237222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
    D'Alessio DA; Vahl TP
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E882-90. PubMed ID: 15140755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.